Patents by Inventor Van de Casteele Russell

Van de Casteele Russell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the delivery of a biologically active agent
    Publication number: 20100062072
    Abstract: A method of manufacturing a stable nanosuspension for delivery of a biologically active agent into the bloodstream of a subject is disclosed. A microfluidizable mixture is initially formed and processed via a microfluidization process to form the stable nanosuspension, which may be administered via the buccal mucosa or other suitable routes of administration. This product demonstrates increased bioavailability, enhanced period of onset, and enhanced stability for a controlled-release product.
    Type: Application
    Filed: November 16, 2009
    Publication date: March 11, 2010
    Inventor: Van de Casteele Russell
  • Method for the delivery of a biologically active agent
    Publication number: 20060233844
    Abstract: A method of manufacturing a stable nanosuspension for delivery of a biologically active agent into the bloodstream of a subject is disclosed. A microfluidizable mixture is initially formed and processed via a microfluidization process to form the stable nanosuspension, which may be administered via the buccal mucosa or other suitable routes of administration. This product demonstrates increased bioavailability, enhanced period of onset, and enhanced stability for a controlled-release product.
    Type: Application
    Filed: June 27, 2006
    Publication date: October 19, 2006
    Inventor: Van de Casteele Russell
  • Method for the delivery of a biologically active agent
    Publication number: 20050147688
    Abstract: A method of manufacturing a stable nanosuspension for delivery of a biologically active agent into the bloodstream of a subject is disclosed. A microfluidizable mixture is initially formed and processed via a microfluidization process to form the stable nanosuspension, which may be administered via the buccal mucosa or other suitable routes of administration. This product demonstrates increased bioavailability, enhanced period of onset, and enhanced stability for a controlled-release product.
    Type: Application
    Filed: February 11, 2005
    Publication date: July 7, 2005
    Inventor: Van de Casteele Russell
  • Method for the delivery of a biologically active agent
    Publication number: 20030170311
    Abstract: A method of manufacturing a stable nanosuspension for delivery of a biologically active agent into the bloodstream of a subject is disclosed. A microfluidizable mixture is initially formed and processed via a microfluidization process to form the stable nanosuspension, which may be administered via the buccal mucosa or other suitable routes of administration. This product demonstrates increased bioavailability, enhanced period of onset, and enhanced stability for a controlled-release product.
    Type: Application
    Filed: March 11, 2002
    Publication date: September 11, 2003
    Inventor: Van de Casteele Russell